| Product Code: ETC6173085 | Publication Date: Sep 2024 | Updated Date: Aug 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | Author: Vasudha | No. of Pages: 75 | No. of Figures: 35 | No. of Tables: 20 |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 Australia AI In Oncology Market Overview |
3.1 Australia Country Macro Economic Indicators |
3.2 Australia AI In Oncology Market Revenues & Volume, 2021 & 2031F |
3.3 Australia AI In Oncology Market - Industry Life Cycle |
3.4 Australia AI In Oncology Market - Porter's Five Forces |
3.5 Australia AI In Oncology Market Revenues & Volume Share, By Component Type, 2021 & 2031F |
3.6 Australia AI In Oncology Market Revenues & Volume Share, By Cancer Type, 2021 & 2031F |
3.7 Australia AI In Oncology Market Revenues & Volume Share, By Application, 2021 & 2031F |
3.8 Australia AI In Oncology Market Revenues & Volume Share, By End-use Type, 2021 & 2031F |
4 Australia AI In Oncology Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.2.1 Increasing prevalence of cancer cases in Australia |
4.2.2 Growing adoption of AI technology in healthcare sector |
4.2.3 Demand for personalized and targeted cancer treatment options |
4.2.4 Government initiatives and funding for AI in oncology research and development |
4.3 Market Restraints |
4.3.1 High costs associated with AI technology implementation |
4.3.2 Concerns regarding data privacy and security in AI applications |
4.3.3 Lack of skilled professionals in AI and oncology fields |
4.3.4 Regulatory challenges and compliance issues |
5 Australia AI In Oncology Market Trends |
6 Australia AI In Oncology Market, By Types |
6.1 Australia AI In Oncology Market, By Component Type |
6.1.1 Overview and Analysis |
6.1.2 Australia AI In Oncology Market Revenues & Volume, By Component Type, 2021- 2031F |
6.1.3 Australia AI In Oncology Market Revenues & Volume, By Software Solutions, 2021- 2031F |
6.1.4 Australia AI In Oncology Market Revenues & Volume, By Hardware, 2021- 2031F |
6.1.5 Australia AI In Oncology Market Revenues & Volume, By Services, 2021- 2031F |
6.2 Australia AI In Oncology Market, By Cancer Type |
6.2.1 Overview and Analysis |
6.2.2 Australia AI In Oncology Market Revenues & Volume, By Breast Cancer, 2021- 2031F |
6.2.3 Australia AI In Oncology Market Revenues & Volume, By Lung Cancer, 2021- 2031F |
6.2.4 Australia AI In Oncology Market Revenues & Volume, By Prostate Cancer, 2021- 2031F |
6.2.5 Australia AI In Oncology Market Revenues & Volume, By Colorectal Cancer, 2021- 2031F |
6.2.6 Australia AI In Oncology Market Revenues & Volume, By Brain TumorOthers, 2021- 2031F |
6.3 Australia AI In Oncology Market, By Application |
6.3.1 Overview and Analysis |
6.3.2 Australia AI In Oncology Market Revenues & Volume, By Diagnostics (Pathology, Cancer Radiology), 2021- 2031F |
6.3.3 Australia AI In Oncology Market Revenues & Volume, By Radiation Therapy (Radiotherapy), 2021- 2031F |
6.3.4 Australia AI In Oncology Market Revenues & Volume, By Research & Development (Drug design, development process, etc.), 2021- 2031F |
6.3.5 Australia AI In Oncology Market Revenues & Volume, By Chemotherapy, 2021- 2031F |
6.3.6 Australia AI In Oncology Market Revenues & Volume, By Immunotherapy, 2021- 2031F |
6.4 Australia AI In Oncology Market, By End-use Type |
6.4.1 Overview and Analysis |
6.4.2 Australia AI In Oncology Market Revenues & Volume, By Hospitals, 2021- 2031F |
6.4.3 Australia AI In Oncology Market Revenues & Volume, By Surgical Centers & Medical Institutes, 2021- 2031F |
6.4.4 Australia AI In Oncology Market Revenues & Volume, By Others, 2021- 2031F |
7 Australia AI In Oncology Market Import-Export Trade Statistics |
7.1 Australia AI In Oncology Market Export to Major Countries |
7.2 Australia AI In Oncology Market Imports from Major Countries |
8 Australia AI In Oncology Market Key Performance Indicators |
8.1 Number of clinical trials incorporating AI in oncology in Australia |
8.2 Percentage increase in AI adoption rate by oncology clinics and hospitals |
8.3 Number of partnerships between AI technology providers and oncology institutions |
8.4 Rate of improvement in accuracy and efficiency of AI-powered cancer diagnostics |
8.5 Patient outcomes and survival rates post-implementation of AI in oncology treatments |
9 Australia AI In Oncology Market - Opportunity Assessment |
9.1 Australia AI In Oncology Market Opportunity Assessment, By Component Type, 2021 & 2031F |
9.2 Australia AI In Oncology Market Opportunity Assessment, By Cancer Type, 2021 & 2031F |
9.3 Australia AI In Oncology Market Opportunity Assessment, By Application, 2021 & 2031F |
9.4 Australia AI In Oncology Market Opportunity Assessment, By End-use Type, 2021 & 2031F |
10 Australia AI In Oncology Market - Competitive Landscape |
10.1 Australia AI In Oncology Market Revenue Share, By Companies, 2024 |
10.2 Australia AI In Oncology Market Competitive Benchmarking, By Operating and Technical Parameters |
11 Company Profiles |
12 Recommendations |
13 Disclaimer |